The store will not work correctly when cookies are disabled.
N,N,N-trimethyl-3-bromo-4-methoxytyrosine
ID: ALA3286794
PubChem CID: 90680655
Max Phase: Preclinical
Molecular Formula: C15H19BrF3NO5
Molecular Weight: 317.20
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(CC(C(=O)O)[N+](C)(C)C)cc1Br.O=C([O-])C(F)(F)F
Standard InChI: InChI=1S/C13H18BrNO3.C2HF3O2/c1-15(2,3)11(13(16)17)8-9-5-6-12(18-4)10(14)7-9;3-2(4,5)1(6)7/h5-7,11H,8H2,1-4H3;(H,6,7)
Standard InChI Key: SZGBGLOOKCLDNF-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 24 0 0 0 0 0 0 0 0999 V2000
25.5567 -20.7847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9667 -20.0788 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.7395 -20.7832 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.9637 -21.4933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5536 -22.2001 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.7809 -21.4951 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.3647 -22.1962 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.7462 -19.1132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7450 -19.9327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4531 -20.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1627 -19.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1599 -19.1096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4513 -18.7043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4488 -17.8871 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1553 -17.4764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8661 -18.6983 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
21.4529 -21.1589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1605 -21.5676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1603 -22.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8683 -21.1592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5759 -21.5680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8685 -20.3420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5706 -20.7435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4515 -22.7953 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8669 -22.7956 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
4 5 1 0
4 6 1 0
4 7 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
13 14 1 0
14 15 1 0
12 16 1 0
10 17 1 0
17 18 1 0
18 19 1 0
18 20 1 0
20 21 1 0
20 22 1 0
20 23 1 0
19 24 1 0
19 25 2 0
M CHG 2 2 -1 20 1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 317.20 | Molecular Weight (Monoisotopic): 316.0543 | AlogP: 2.16 | #Rotatable Bonds: 5 |
Polar Surface Area: 46.53 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.42 | CX Basic pKa: ┄ | CX LogP: -1.66 | CX LogD: -0.89 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.85 | Np Likeness Score: 0.81 |
References
1. Tian LW, Feng Y, Shimizu Y, Pfeifer T, Wellington C, Hooper JN, Quinn RJ.. (2014) Aplysinellamides A-C, bromotyrosine-derived metabolites from an Australian Aplysinella sp. marine sponge., 77 (5): [PMID:24758268] [10.1021/np500119e] |